Suchergebnisse - "Rose, April A N"

PubPharm (46)

1

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma : a multicentre retrospective cohort study

enthalten in: BMJ open | 2024

von Labidi, S. | Meti, N. | Barua, R. | +11

2

Clinical activity of Mitogen-Activated Protein Kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers

enthalten in: bioRxiv.org | 2024

von Dankner, M. | Rousselle, E. | Petrecca, S. | +16

3

The role of CRAF in cancer progression : from molecular mechanisms to precision therapies

enthalten in: Nature reviews. Cancer | 2024

von Riaud, M. | Maxwell, J. | Soria-Bretones, I. | +3

4

The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers

enthalten in: Cancers | 2024

von Kazandjian, S. | Rousselle, E. | Dankner, M. | +6

5

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma

enthalten in: bioRxiv.org | 2023

von Labidi, S. | Meti, N. | Barua, R. | +11

6

The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers

enthalten in: bioRxiv.org | 2023

von Kazandjian, S. | Rousselle, E. | Dankner, M. | +6

7

Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy

enthalten in: Cancers | 2023

von Vilbert, M. | Koch, E. | Rose, A. | +8

8

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Lazaratos, A. | Maritan, S. | Quaiattini, A. | +21

9

Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer

enthalten in: Molecular cancer therapeutics | 2023

von Prabhu, S. | Moussa, O. | Gonçalves, C. | +20

10

The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations

enthalten in: Science advances | 2022

von Soria-Bretones, I. | Thu, K. | Silvester, J. | +14

1
2
3
4
5
Nächster »
[5]